Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Great oportunity to buy at this levels , Oficial NEWS soon !
all we know big pharmesuetical companies are watching this story. Buyout is very possible down the road. Woof
last chance people , SELL SCAMs and no important company , this is really huge !!!!!!!!
If you are loossiing you win the looosss here
XKEM really strong BUY 10 times your money
easy 0.15 cents !!!!!!
LaSt minute....... Interesting post found on another board:
By: hardknock () | IP logged
3/13/2006 1:57:27 PM
XKEM For everyone on this board Know that I called it on XKEM Price target by April $0.15
Not Only that I talk to IR FIRM Stephen Burg He told me they had 2 huge buyout offers they turned it down call your self and ask.
They got something the big companys want and with a low o/s shares this will go to the moon.
Feels like PTSC Will be like PTSC And do like PTSC MARK THIS POST WATCH GET IN OR STAY ON THE SIDELINES
Hmmmmm! I wonder how much the buyout offers were for? If anyone speaks to Burg tomorrow ask him if he is willing to share the amount of the buyout offers. tia
UNDER 0.02 Very Strong BUY ..... last chance people PICK UP !!!!
HOLD OLD HOLD very near the succes !!!!!!!
Pandey on the 21st....is the Antimalaria Meeting...
http://www.worldagroforestry.org/treesandmarkets/antimalariameeting/schedule.html
Nigeria to manufacture anti-AIDS malaria, and sickle cell anaemia drugs
The Federal Government said yesterday that the country would go into local manufacture of anti-retroviral drugs (ARVs) and the artemisinin containing therapies for malaria (ACTs). Government also disclosed that another local pharmaceutical manufacturing plant for the production of "nicosan", a pytomedicine for the management of sickle cell anaemia would be built in Abuja.
Speaking in Abuja at the opening of the National Institute for Phamarceutical Research (NIPDR) training course on Good Manufacturing Practices for Pharmaceuticals and How to Manage Clinical Trials, the Minister of State for Health, Princess Funke Adedoyin, said the country would soon go into the manufacturing of the aforesaid drugs. "Hosting this course at this point in time in my opinion is very timely because Nigeria is one of the countries that will soon start the local manufacturing of the ARVs and ACTs. There is a compelling need for our pharmaceutical and clinical research experts to update their knowlege and skills of these phamaceutical products", she said.
She noted that "it is hoped that the NIPRD with its cadre of scientific personnel will soon begin to show interest in the synthesis and formuation studies of ARVs and ACTs. We must also encourage and build adequate capacity for the local production of these medicines and ensure that their quality comply with all established international standards". She commended the private firm of Xechem International and the Howard University Pace Center for collaborating with the NIPRD in the organisation of this course. She said the Xechem firm was building the said local pharmaceutical manufacturing plant in Abuja for the production of "nicosan".
news news news news sooooonnnnn !!!!!!!!!!
Information about amsterdamnews.com:
Site Stats for amsterdamnews.com:
Traffic Rank for amsterdamnews.com: 1,211,888 (698,911)
Speed: Not available (what's this?)
Other sites that link to this site: 22
Online Since: 23-Sep-1997
See Traffic Detail...
Contact Info for amsterdamnews.com:
Amsterdam News
2340 Frederick Douglass Blvd
New York, NY
10027
US
+1 410 276 0010, Fax: +1 410 276 0090
xigdomains@xigroup.com
Information about businessdayonline.com
Site Stats for businessdayonline.com
Traffic Rank for businessdayonline.com: 426,956 (487,093)
Speed: Average (54% of sites are faster), Avg Load Time: 1.8 Seconds (what's this?)
Other sites that link to this site: 4
Online Since: 22-Jul-2003
See Traffic Detail...
Contact Info for businessdayonline.com:
BusinessDAY Media Ltd
2 Vivian Pl, Victoria Park
Manchester M14 5QQ,
UNITED KINGDOM
+44 1612259772
philisakpa@aol.com
XKEM ---- last chance to Buy Under 0.0250 -0.3
dont wait for the rally , when Oficial News out ---this GEM dont stop under 0.10 cents
Pandey on the 21st....is the Antimalaria Meeting...
http://www.worldagroforestry.org/treesandmarkets/antimalariameeting/schedule.html
BUy early at 0.0210 ---- good prize
from yahoo board
Like most of the people here, I too have been following XKEM for
some time now. I work in the biotech field and from what I see, XKEM
has a bright future ahead of it....
Having completed the Phase I and Phase II trials, there is little
stoping this drug from going to market. Fast-track status is a given,
since the need is high, and there is no market leaders to compete
with. The sales will start the moment the regist. documents are
finished. Mind you, in Africa, like other most other countries, the
State buys the majority of all medications that enter is borders.
Hospitals,Insurance Groups and the Military are the largest biders and
distributors of medicine, which are all State owned. Once sales
initiate in one country, going through the rest of Afric is quite easy
throught the African Union, joint regulatory filings. Once approved in
one, the rest will follow. So interms of sales, it's not the people
that will buy, it's the state that will buy.
As of Sales, an Impact Assement is still low, ~20 Mil people Max
in Africa, probably another ~5-10 Mil world-wide. Thats low period.
Revenue would not exceed ~400 Mil per year, with a 5-15 % decline in
sales over the first 5 yrs and 20-40% for the next 5-10 yrs. So that
might help explain why the stock hasn't yet shot through the roof.
As for the production this June/July, most don't realize that
prior to initiating a Phase I/II/ or III trials the company has to
prove that it can produce sufficent active compound at the cGMP/cGLP
standards inorder to conduct these trials. In doing so, it provides an
insite into the facilites/production sites which must already be in
place!
As for initial capitial, the 4.1 Mil recently received is nothing,
to initiate this type of campaign you need ~15-25Mil to start, even
with production in Africa.
However, with a high demand for this drug and little to stop it, I
have no doubts that it will make the markets this summer. With a
market cap of ~8 Mil, this is very under valued.
Stong Buy........
(Voluntary Disclosure: ST Rating- Strong Buy; LT Rating- Strong Buy)
- - - - -
Yes but this answer is for the Vice president of XKEM Nigeria !
By: gaycrisis ...... very interesting read !!!
12 Mar 2006, 02:11 PM EST
Msg. 12377 of 12384
Jump to msg. #
XKEM Nigeria emailed me look:
From : Xechem Pharmaceutical Nig. Ltd.
Sent : Saturday, March 11, 2006 2:10 PM
To : XXXX
CC : Ramesh Pandey
Subject : Re: Information
Dear Mr. XXXX
Thank you for your e-mail of March 10, 2006.
The launch of NICOSAN™ is expected during the first half of 2006.
Please feel free to write if you have any other questions.
Thank you and best regards.
Sincerely,
Col. Bhuwan C. Pandey
Vice President / General Manager
cc: Dr. Ramesh C. Pandey (Ramesh(@)xechem(.)com)
Chairman & CEO
Xechem Group
army you bought BWDI an Scam ..... and you think if you buy XKEM ..........really an amazing produt for 25 millions of persons waiting for it !
soorry army you are wrong , they not convert nothing.
soorry i dont speak spanish
By: bmagoo
12 Mar 2006, 01:16 PM EST
Msg. 12342 of 12348
Jump to msg. #
I`ve been toying wiyh the idea of investing into this stock, but the O /S has kept me from investing. NOW however this link, has changed my mind. MONDAY. I`m calling my broker LINK http://www.watchtower.org/library/g/1996/10/8/anemia_knowledge_defense.htm Bmagoo
jajjajajajaj my candidate !!!!!
Nobel for Pandey -the ilness is very serious ---read this
http://www.watchtower.org/library/g/1996/10/8/anemia_knowledge_defense.htm
good hurley - good post ''' easy xkem .20 cents
Good NEWs in this conference ?
XKEm Nigeria Pandey Conference in AFRICA ! look http://www.worldagroforestry.org/treesandmarkets/antimalariameeting/schedule.html
yes but I try , under 0.0220 is good for me
I pick up more at 2 early MONDAY .... at 0.02 -0.0210
very good POSt.... all is true !
1,000,000 ------ army '''' very good my shares prize above .20
We wait for oficial news rhis week , about the update of the company
im long here !
XKEm Nigeria Pandey Conference in AFRICA ! look http://www.worldagroforestry.org/treesandmarkets/antimalariameeting/schedule.html
something NEW here ?
perhaps 0.03 cents?
opinions for this week please . Im in 0.0176
XKEM----- partner read About Alembic
Alembic is a 97 year old pharmaceutical firm based in Baroda, India. It has obtained ISO-9002, ISO-14001 and WHO-GMP Certifications. Its R&D facilities spearhead landmark research in the areas of chemistry, neurology and pharmaceutical technology and distributes its product to over 75 countries throughout the world.
About Xechem
Xechem International, Inc. is a fully integrated biopharmaceutical company focusing on phytopharmaceuticals and other proprietary technologies for orphan diseases. Its mission is to increase the quality and quantity of life of the people who suffer from these diseases.
This news release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by safe harbors created hereby. Such forward-looking statements involve known and unknown risks, uncertainties, including the ability of the Company to obtain necessary regulatory approval for the launch of NICOSAN(TM)/HEMOXIN(TM) in Nigeria and elsewhere, the ability of the Company to fund the cost of development and operation of a manufacturing financing and distribution network for NICOSAN(TM)/HEMOXIN(TM) in Nigeria, the ability to meet its financial obligations to Alembic and others in connection with such project and the ability to raise additional capital, domestically or in Nigeria to fund such project and its other operations, and the amount of dilution to be experienced in Nigeria. Other factors that may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements of the Company expressed or implied by such forward-looking statements.
--------------------------------------------------------------------------------
Contact:
Xechem International, Inc.
Ramesh C. Pandey, Ph.D.
732-247-3300; 732-247-4090 fax
xechem@erols.com
or
Wolfe Axelrod Weinberger Assoc. LLC
Donald C. Weinberger
Andria Arena (Media)
212-370-4500; 212-370-4505 fax
don@wolfeaxelrod.com
andria@wolfeaxelrod.com
--------------------------------------------------------------------------------
Source: Xechem International, Inc.
rick continue here .....huacala huacala
macchu pense que estabas en la carcel ganso !
good prize no?